Tabla de Contenidos: “…- Clinical and Statistical Considerations when Assessing Oxygen Levels in Tumors: Illustrative Results from Clinical EPR Oximetry Studies -- Fatal Alliance of Hypoxia-/HIF-1α-driven Microenvironmental Traits Promoting Cancer Progression -- Quantification of Tumor Oxygenation based on FMISO PET: Influence of Location and Oxygen Level of the Well-Oxygenated Reference Region -- Pathways of Oxygen Diffusion in Cells and Tissues: Hydrophobic channeling via networked lipids -- Part III Muscle Oxygenation and Sports Medicine -- Effect of Exercise Duration on Post-exercise Persistence of Oxyhemoglobin Changes in the Premotor Cortex: A Near-infrared Spectroscopy Study in Moderate-intensity Cycling Exercise -- Relationship Between Muscle Oxygen Saturation and Exercise Load in Patients with Malignant Hematopoietic Disease -- Comparison of the Effects of Continuous and Intermittent Exercise on Cerebral Oxygenation and Cognitive Function -- Relationship between Exercise Capacity and Muscle O2Hb saturation in Patients before Hematopoietic Stem-Cell Transplantation -- Differences in Muscle O2 Dynamics During Treadmill Exercise Between Aerobic Capacity-matched Overweight and Normal-weight Adults -- Cerebral Oxygenation Dynamics of the Prefrontal Cortex and Motor-Related Area During Cardiopulmonary Exercise Test: A Near-infrared Spectroscopy Study -- Reduced Optical Path Length in the Vastus Lateralis during Ramp Cycling Exercise -- Improvements in Skeletal Muscle can be Detected using Broadband NIRS in First-Time Marathon Runners -- Comparison of Two NIRS Tissue Oximeters (Moxy and Nimo) for Non-invasive Assessment of Muscle Oxygenation and Perfusion -- Part IV Cell Metabolism and Tissue Oxygenation -- Effects of Pulsed Magnetic Field on the Hemolysis of Erythrocytes Exposed to Oxidative Stress -- Role of Microtubule-associated Factors in HIF1α Nuclear Translocation -- Extracellular Acidosis Regulates the Expression of Inflammatory Mediators in Rat Epithelial Cells -- Part V Methodology of O2 Measurements -- Reducing False Alarm Rates in Neonatal Intensive Care: A New Machine Learning Approach -- Development of an IoT-based Monitoring System for Healthcare: A Preliminary Study -- Developing a Model to Simulate the Effect of Hypothermia on Cerebral Blood Flow and Metabolism -- Validation and Comparison of Monte Carlo and Finite Element Method in Forward Modeling for Near Infrared Optical Tomography -- Development of a Cuff-less Blood Pressure Monitoring System and its Application -- Usefulness of a New Device to Monitor Cerebral Blood Oxygenation using NIRS during Cardiopulmonary Resuscitation in Patients with Cardiac Arrest: A Pilot Study -- Application of Peripheral Near Infrared Spectroscopy to Assess Risk Factors in Patient with Coronary Artery Disease: Part 1 -- Broadband NIRS Cerebral Evaluation of the Hemodynamic and Oxidative State of Cytochrome-c-oxidase Responses to +Gz Acceleration in Healthy Volunteers -- Time-resolved NIROT ‘Pioneer’ System for Imaging Oxygenation of the Preterm Brain: Preliminary Results -- Application of Peripheral Near Infrared Spectroscopy to Assess Risk Factors in Patient with Coronary Artery Disease: Part 2 -- Optimization of Band Selection in Multispectral and Narrow-Band Imaging: An Analytical Approach -- Fabrication and Optical Characterization of Gelatin-Based Phantoms for Tissue Oximetry -- Two-Photon Autofluorescence Imaging of Fixed Tissues: Feasibility and Potential Values for Biomedical Applications -- Part VI Special Topics -- Acute Anemia Induces Erythropoiesis in Rat Organ Surface Primo-Vascular Tissue -- Analysis and Differential Expression of Primo Genes using RNA-Seq and qRT-PCR Experiments -- Acupuncture Inhibits the Increase in Alpha-synuclein in Substantia nigra in an MPTP- induced Parkinsonism Mouse Model -- On the Biomarkers of Alzheimer’s Disease -- Effective Murine Model Induction for Niche Study in Immune Cells against Leukemia -- Index…”

Tabla de Contenidos: “…. -- ELEMENTS OF SUCCESSFUL INTERVENTIONS ACROSS THE CONTINUUM OF POPULATION RISK -- Interventions for Level IV Populations -- Interventions for Level III Populations -- Interventions for Level II Populations -- INTERVENTIONS FOR LEVEL I POPULATIONS -- Balancing Approaches to Country-Specific Circumstances -- Coordinating Interventions Across Micronutrients -- COMMON ELEMENTS OF SUCCESSFUL MICRONUTRIENT INTERVENTIONS -- Political Will/Stability -- Strategic and Program Planning -- Community Involvement, Participation, and Consumer Demand -- Physical and Administrative Infrastructure -- Communications Strategies -- Use of Appropriate Vehicle -- Sustainability -- Information Systems, Monitoring, and Evaluation -- Biological Indicators -- Background Papers -- 3 Prevention of Iron Deficiency -- DIAGNOSIS OF IRON DEFICIENCY AND ANEMIA -- CAUSES OF IRON DEFICIENCY -- IRON EXCESS -- PREVENTION OF IRON DEFICIENCY IN AT-RISK GROUPS -- Infancy -- Preschool Children (3 to &lt -- 7 Years of Age) -- School-Age Children and Adolescents -- Women of Childbearing Age -- Pregnant Women…”

Tabla de Contenidos: “…Section 1: Foundation Issues -- Chapter e1: Health Literacy and Medication Use -- Chapter e2: Cultural Competency -- Chapter e3: Medication Safety Principles and Practices -- Chapter e4: Clinical Pharmacokinetics and Pharmacodynamics -- Chapter e5: Pharmacogenetics -- Chapter e6: Pediatrics -- Chapter e7: Geriatrics -- Chapter e8: Palliative Care -- Chapter e9: Clinical Toxicology -- Chapter e10: Clinical Management of Potential Bioterrorism-related Conditions -- Section 2: Cardiovascular Disorders -- Chapter e11: Cardiovascular Testing -- Chapter 12: Cardiac Arrest -- Chapter 13: Hypertension -- Chapter 14: Chronic Heart Failure -- Chapter 15: Acute Decompensated Heart Failure -- Chapter 16: Stable Ischemic Heart Disease -- Chapter 17: Acute Coronary Syndromes -- Chapter 18: The Arrhythmias -- Chapter 19: Venous Thromboembolism -- Chapter 20: Stroke -- Chapter 21: Dyslipidemia -- Chapter e22: Peripheral Arterial Disease -- Chapter 23: Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock -- Chapter 24: Hypovolemic Shock -- Chapter e25: Introduction to Pulmonary Function Testing -- Section 3: Respiratory Disorders -- Chapter 26: Asthma -- Chapter 27: Chronic Obstructive Pulmonary Disease -- Chapter 28: Pulmonary Arterial Hypertension -- Chapter 29: Cystic Fibrosis -- Chapter e30: Drug-Induced Pulmonary Diseases -- Section 4: Gastrointestinal Disorders -- Chapter e31: Evaluation of the Gastrointestinal Tract -- Chapter 32: Gastroesophageal Reflux Disease -- Chapter 33: Peptic Ulcer Disease and Related Disorders -- Chapter 34: Inflammatory Bowel Disease -- Chapter 35: Nausea and Vomiting -- Chapter 36: Diarrhea, Constipation, and Irritable Bowel Syndrome -- Chapter 37: Portal Hypertension and Cirrhosis -- Chapter e38: Drug-Induced Liver Disease -- Chapter 39: Pancreatitis -- Chapter 40: Viral Hepatitis -- Chapter 41: Celiac Disease -- Section 5: Renal Disorders -- Chapter e42: Evaluation of Kidney Function -- Chapter 43: Acute Kidney Injury -- Chapter 44: Chronic Kidney Disease -- Chapter 45: Hemodialysis and Peritoneal Dialysis -- Chapter 46: Drug-Induced Kidney Disease -- Chapter 47: Glomerulonephritis -- Chapter 48: Drug Therapy Individualization for Patients with Chronic Kidney Disease -- Chapter 49: Disorders of Sodium and Water Homeostasis -- Chapter 50: Disorders of Calcium and Phosphorus Homeostasis -- Chapter 51: Disorders of Potassium and Magnesium Homeostasis -- Chapter 52: Acid-Base Disorders -- Section 6: Neurologic Disorders -- Chapter e53: Evaluation of Neurologic Illness -- Chapter 54: Alzheimer Disease -- Chapter 55: Multiple Sclerosis -- Chapter 56: Epilepsy -- Chapter 57: Status Epilepticus -- Chapter 58: Acute Management of the Brain Injury Patient -- Chapter 59: Parkinson Disease -- Chapter 60: Pain Management -- Chapter 61: Headache Disorders -- Section 7: Psychiatric Disorders -- Chapter e62: Assessment of Psychiatric Disorders -- Chapter 63: Attention Deficit/Hyperactivity Disorder -- Chapter 64: Eating Disorders -- Chapter 65: Substance-Related Disorders I: Overview and Depressants, Stimulants, and Hallucinogens -- Chapter 66: Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine -- Chapter 67: Schizophrenia -- Chapter 68: Major Depressive Disorder -- Chapter 69: Bipolar Disorder -- Chapter 70: Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders.5050 Chapter 71: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder -- Chapter 72: Sleep-Wake Disorders -- Chapter 73: Disorders Associated with Intellectual Disabilities -- Section 8: Endocrinologic Disorders -- Chapter 74: Diabetes Mellitus -- Chapter 75: Thyroid Disorders -- Chapter 76: Adrenal Gland Disorders -- Chapter e77: Pituitary Gland Disorders -- Section 9: Gynecologic and Obstetric Disorders -- Chapter 78: Pregnancy and Lactation: Therapeutic Considerations -- Chapter 79: Contraception -- Chapter 80: Menstruation-Related Disorders -- Chapter 81: Endometriosis -- Chapter 82: Hormone Therapy in Women -- Section 10: Urologic Disorders -- Chapter 83: Erectile Dysfunction -- Chapter 84: Benign Prostatic Hyperplasia -- Chapter 85: Urinary Incontinence -- Section 11: Immunologic Disorders -- Chapter e86: Function and Evaluation of the Immune System -- Chapter 87: Systemic Lupus Erythematosus -- Chapter e88: Drug Allergy -- Chapter 89: Solid-Organ Transplantation -- Section 12: Rheumatologic Disorders -- Chapter 90: Osteoarthritis -- Chapter 91: Rheumatoid Arthritis -- Chapter 92: Osteoporosis and Osteomalacia -- Chapter 93: Gout and Hyperuricemia -- Section 13: Ophthalmic and Otolaryngological Disorders -- Chapter 94: Glaucoma -- Chapter 95: Allergic Rhinitis -- Section 14: Dermatologic Disorders -- Chapter 96: Acne Vulgaris -- Chapter 97: Psoriasis -- Chapter 98: Atopic Dermatitis -- Chapter e99: Dermatologic Drug Reactions and Common Skin Conditions -- Section 15: Hematologic Disorders -- Chapter 100: Anemias -- Chapter 101: Coagulation Disorders -- Chapter 102: Sickle Cell Disease -- Chapter e103: Drug-Induced Hematologic Disorders -- Section 16: Infectious Diseases -- Chapter e104: Laboratory Tests to Direct Antimicrobial Pharmacotherapy -- Chapter 105: Antimicrobial Regimen Selection -- Chapter 106: Central Nervous System Infections -- Chapter 107: Lower Respiratory Tract Infections -- Chapter 108: Upper Respiratory Tract Infections -- Chapter 109: Influenza -- Chapter 110: Skin and Soft-Tissue Infections -- Chapter 111: Infective Endocarditis -- Chapter 112: Tuberculosis -- Chapter 113: Gastrointestinal Infections and Enterotoxigenic Poisonings -- Chapter 114: Intra-Abdominal Infections -- Chapter 116: Urinary Tract Infections and Prostatitis -- Chapter e115: Parasitic Diseases -- Chapter 117: Sexually Transmitted Diseases -- Chapter 118: Bone and Joint Infections -- Chapter 119: Sepsis and Septic Shock -- Chapter 120: Superficial Fungal Infections -- Chapter 121: Invasive Fungal Infections -- Chapter 122: Infections in Immunocompromised Patients -- Chapter 123: Antimicrobial Prophylaxis in Surgery -- Chapter e124: Travel Health -- Chapter 125: Vaccines and Immunoglobulins -- Chapter 126: Human Immunodeficiency Virus Infection -- Section 17: Oncologic Disorders -- Chapter 127: Cancer Treatment and Chemotherapy -- Chapter 128: Breast Cancer -- Chapter 129: Lung Cancer -- Chapter 130: Colorectal Cancer -- Chapter 131: Prostate Cancer -- Chapter 132: Lymphomas -- Chapter 133: Ovarian Cancer -- Chapter 134: Acute Leukemias -- Chapter 135: Chronic Leukemias -- Chapter 136: Multiple Myeloma -- Chapter e137: Myelodysplastic Syndromes -- Chapter e138: Renal Cell Carcinoma -- Chapter 139: Melanoma -- Chapter 140: Hematopoietic Stem Cell Transplantation -- Section 18: Nutritional Disorders -- Chapter 141: Assessment of Nutrition Status and Nutrition Requirements -- Chapter 142: Parenteral Nutrition -- Chapter 143: Enteral Nutrition -- Chapter 144: Obesity…”

Tabla de Contenidos: “…ASSESSING GENETIC RISKS -- Copyright -- Preface -- ADDITIONAL VIEWS OF THE CHAIRMAN -- Acknowledgments -- Contents -- Executive Summary -- PROMISE AND PROBLEMS IN GENETIC TESTING -- COMMITTEE ON ASSESSING GENETIC RISKS -- GENETIC TESTING AND ASSESSMENT -- Newborn Screening -- Carrier Identification -- Prenatal Diagnosis -- Testing for Late-Onset Disorders -- Testing of Children or Minors -- LABORATORY ISSUES IN GENETIC TESTING -- Genetic Tests for Rare Disorders -- CLIA88 -- Genetic Tests and the FDA -- GENETIC COUNSELING -- Basic Tenets of Genetic Counseling -- Tailoring Counseling to the Client -- PUBLIC EDUCATION -- PROFESSIONAL EDUCATION -- FINANCING OF GENETIC TESTING SERVICES -- SOCIAL, LEGAL, AND ETHICAL ISSUES IN GENETIC TESTING -- Voluntariness -- Informed Consent -- Confidentiality -- Genetic Discrimination in Health Insurance -- Genetic Discrimination in Employment -- RESEARCH AND POLICY AGENDA -- Policy Oversight -- Research Policy -- Need for Additional Standards -- Policy Research Needs -- 1 Setting the Stage -- RECOMBINANT DNA TECHNOLOGY, GENE MAPPING, AND IDENTIFICATION OF DISEASE-RELATED GENES -- Implications of Recombinant DNA Technology for Genetic Testing -- Other Recent Advances and Their Implications for Genetic Testing -- Limitations of Genetic Testing -- LESSONS FROM THE PAST -- Phenylketonuria -- Sickle Cell Anemia and Trait -- Tay-Sachs Disease and Trait -- Thalassemia -- UPDATING THE FINDINGS OF THE 1975 NAS COMMITTEE -- Aims of Testing and Screening -- Criteria for Testing -- Quality of Testing -- Conflicts of Interest -- Pilot Studies -- Auspices and Settings -- Standards of Care -- Age for Testing -- Education of the Public -- Ethical Issues -- Allocation of Resources -- Recognition of Human Diversity and Respect and Tolerance for People with Disabilities -- REFERENCES -- 2 Genetic Testing and Assessment…”

Tabla de Contenidos: “…1.13.6 Applying Cognition to Develop Health and Wellness -- 1.13.7 Welltok -- 1.13.8 CaféWell Concierge in Action -- 1.14 Advantages of Cognitive Computing -- 1.15 Features of Cognitive Computing -- 1.16 Limitations of Cognitive Computing -- 1.17 Conclusion -- References -- 2 Machine Learning and Big Data in Cyber-Physical System: Methods, Applications and Challenges -- 2.1 Introduction -- 2.2 Cyber-Physical System Architecture -- 2.3 Human-in-the-Loop Cyber-Physical Systems (HiLCPS) -- 2.4 Machine Learning Applications in CPS -- 2.4.1 K-Nearest Neighbors (K-NN) in CPS -- 2.4.2 Support Vector Machine (SVM) in CPS -- 2.4.3 Random Forest (RF) in CPS -- 2.4.4 Decision Trees (DT) in CPS -- 2.4.5 Linear Regression (LR) in CPS -- 2.4.6 Multi-Layer Perceptron (MLP) in CPS -- 2.4.7 Naive Bayes (NB) in CPS -- 2.5 Use of IoT in CPS -- 2.6 Use of Big Data in CPS -- 2.7 Critical Analysis -- 2.8 Conclusion -- References -- 3 HemoSmart: A Non-Invasive Device and Mobile App for Anemia Detection -- 3.1 Introduction -- 3.1.1 Background -- 3.1.2 Research Objectives -- 3.1.3 Research Approach -- 3.1.4 Limitations -- 3.2 Literature Review -- 3.3 Methodology -- 3.3.1 Methodological Approach -- 3.3.2 Methods of Analysis -- 3.4 Results -- 3.4.1 Impact of Project Outcomes -- 3.4.2 Results Obtained During the Methodology -- 3.5 Discussion -- 3.6 Originality and Innovativeness of the Research -- 3.6.1 Validation and Quality Control of Methods -- 3.6.2 Cost-Effectiveness of the Research -- 3.7 Conclusion -- References -- 4 Advanced Cognitive Models and Algorithms -- 4.1 Introduction -- 4.2 Microsoft Azure Cognitive Model -- 4.2.1 AI Services Broaden in Microsoft Azure -- 4.3 IBM Watson Cognitive Analytics -- 4.3.1 Cognitive Computing -- 4.3.2 Defining Cognitive Computing via IBM Watson Interface -- 4.3.3 IBM Watson Analytics -- 4.4 Natural Language Modeling…”

Tabla de Contenidos: “…Malformation -- Deformation -- Disruption -- Dysplasia -- Diagnostic Approach to the Dysmorphic Foetus -- Single-system defect -- Syndrome -- Sequence/cascade -- Teratology -- Environmental risk parameters or modifiers -- Basic Principles of Teratology -- Developmental Milestones -- Normal development -- Developmental delay -- Diagnosis -- Identification -- Developmental disorders -- Learning disability (LD) -- Attention deficit hyperactivity disorder (ADHD)-Behavioural disorder -- Review Questions -- Chapter 18: Neural Tube Defects -- Screening of NTD with Maternal Serum Alpha-Fetoprotein (AFP) -- Ultrasound Evaluation of NTDS -- Prevention of NTD -- Genetic Susceptibility for NTD and Folic Acid Intake -- Fortification During Pregnancy -- Review Questions -- Chapter 19: The Nature of Cancer -- Cancer as a Genetic Disease -- The clonal evolution of tumours -- The role of environment in cancer -- Genes that contribute to cancer -- DNA Repair Genes -- Genes affecting chromosome segregation -- Sequences that regulate telomerase -- Genes that promote vascularization and the spread of tumours -- Chromosome Mutations and Cancer -- The Molecular Genetics of Colorectal Cancer -- Review Questions -- Chapter 20: Inborn Errors of Metabolism -- Classification of Inherited Metabolic Diseases -- Enzyme Defects (Aminoacidopathies) -- Defects in Purine Metabolism (Lesch Nyhan Syndrome) -- Lysosomal Storage Diseases -- Tay Sach's disease -- Mucopolysaccharidoses -- Chapter 21: Haematological Disorders and Genetic Haemochromatosis -- Haemoglobinopathies -- Haemolytic anemias-Sickle cell disease -- Thalassemia -- Alpha thalassemias -- Beta thalassemias -- Genetic Haemochromatosis (GH) -- Review Questions -- Chapter 22: Mental Illness/Mental Disorder -- Normal Mental Health -- Diagnosis -- Management options -- Review Questions -- Chapter 23: The Human Genome Project…”

Tabla de Contenidos: “…FUNCTIONAL CONSEQUENCES OF FEMALE NUTRITIONAL STATUS: TAKING A LIFE SPAN PERSPECTIVE -- Mortality and Morbidity -- Mortality -- Morbidity -- Cognitive Development and School Performance -- Reproductive Function -- Physical Work Capacity -- CONCLUSIONS -- RESEARCH NEEDS -- Notes -- References -- 4 Obstetric Morbidity and Mortality -- GENDER BURDEN -- THE LIFE SPAN: AN APPROACH TO MATERNAL MORBIDITY AND MORTALITY -- Childhood -- Adolescence -- Menopause and Postmenopause -- THE MAGNITUDE OF PREGNANCY-RELATED MORTALITY AND MORBIDITY -- Quantification of Maternal Mortality -- Vital Statistics -- Health Services Statistics -- Population-Based Data -- Alternative Approaches -- The Burden of Maternal Mortality and Morbidity -- Percent of Pregnancy-Related Deaths and Lifetime Risk of Dying -- Estimates of Maternal Morbidity -- Trends -- THE NATURE OF MATERNAL MORTALITY AS A PUBLIC HEALTH PROBLEM -- Prediction, Prevention, and Cure -- Prediction: Risk Factors and the Utility of Risk Scores -- Maternal Characteristics -- Community Characteristics -- Calculations of Risk -- Prevention -- Cure -- THE MULTIPLE CAUSALITY OF MATERNAL DEATH -- Clinical Causes -- Anemia -- Complications of Pregnancy and Delivery -- Sociocultural Factors: Traditional Medical Practices -- The Traditional Birth Attendant -- Gishiri Cuts -- Female Genital Mutilation (FGM) -- Health Services -- Access to Antenatal and Intrapartum Care -- MATERNAL HEALTH AND FAMILY PLANNING -- Provision of Family Planning Services -- Abortion -- Lactation -- MENOPAUSE -- CONCLUSIONS -- RESEARCH NEEDS -- References -- 5 Nervous System Disorders -- LIFE SPAN PERSPECTIVE -- TOXIC AND NUTRITIONAL DISORDERS OF THE NERVOUS SYSTEM -- HEADACHE SYNDROMES -- Migraine -- Tension Headache -- CEREBROVASCULAR DISEASES AND USE OF ORAL CONTRACEPTIVES -- OTHER NEUROLOGICAL DISORDERS -- Epilepsies -- Demyelinating Diseases…”

Tabla de Contenidos: “…Nutrition -- HUNGER -- SPECIFIC NUTRITIONAL RISK FACTORS -- Hypertension -- Cholesterol -- Obesity -- Anorexia and Bulimia -- Anemia -- SPECIAL TARGET GROUPS -- Pregnant Women -- Infants and Children…”

Tabla de Contenidos: “…3 Dolor por cáncer -- Dolor óseo metatásico -- Dolor visceral -- Dolor neuropático -- Cefalea -- Compresión tumoral de la médula espinal -- Dolor causado por cirugía por cáncer -- Cuadros dolorosos preexistentes -- Tratamiento -- Recomendaciones clínicas de la OMS sobre analgesia -- Compresión tumoral de la médula espinal -- Bloqueos por cáncer -- Radioterapia -- 4 Dolor abdominal -- Visceral -- Somático -- Dolor crónico poscirugía abdominal -- Dolor referido -- Tratamiento -- Modificación del estilo de vida -- Tratamiento por categoría -- 5 Dolor pélvico -- Causas comunes de dolor pélvico crónico -- Diagnósticos frecuentes de dolor pélvico crónico -- Dolor pélvico visceral -- Dolor pélvico somático -- Dolor pélvico neuropático -- Tratamiento -- Fármacos -- Inyecciones -- Cirugía -- 6 Dolor en pie y tobillo -- Dolor en el talón y planta del pie -- Fascitis plantar -- Dolor en la cara lateral del primer dedo -- Hallux valgus (juanete) -- Dolor entre el 3o y 4o dedos -- Neuroma de Morton -- Dolor desde el maléolo interno hacia el pie -- Síndrome del túnel tarsiano -- Dolor en ambos pies -- Neuropatía diabética periférica -- 7 Trastornos dolorosos variados que afectan diferentes áreas del cuerpo -- Síndrome de dolor regional complejo (antes conocido como distrofia simpática refleja o causalgia) -- Anamnesis y examen físico -- Tratamiento -- Fibromialgia -- Anamnesis y examen físico -- Tratamiento -- Anemia drepanocítica -- Anamnesis y examen físico -- Tratamiento -- 8 Dolor posoperatorio -- Efectos del dolor posoperatorio -- Efectos fisiológicos -- Efectos funcionales -- Efectos psicológicos -- Efectos del dolor crónico -- Tratamiento -- Medicación intravenosa en bolo -- Analgesia epidural -- Analgesia controlada por el paciente (ACP) -- Analgesia controlada por el paciente versus analgesia epidural -- PARTE II: Tratamientos no intervencionistas…”

“…They or their families are affected by Huntington's disease, Alzheimer's disease, cancer, genetic deafness or blindness, schizophrenia, cystic fibrosis, Tay-Sachs, hypertrophic cardiomyopathy, fragile X, or Fanconi anemia. All of their stories remind us that genetic health is complicated, dynamic, and above all, deeply personal…”

“…Este libro brinda respuestas concretas a tales interrogantes y a muchos otros, pues en sus páginas se encontrarán precisas indicaciones acerca de la alimentación más adecuada para los trastornos gastrointestinales, afecciones hepáticas, enfermedad celiaca, diabetes,obesidad, delgadez, hipertensión, problemas cardíacos, dolencias renales, alergias o anemias, entre otras. En cada caso, se proponen diversas dietas que incluyen las recetas correspondientes, explicadas con gran sencillez y claridad. …”

“…Besides, as a result of these deficiencies, different health conditions, such as depression, anemia, loss of neuronal plasticity, and cancer, are widely scrutinized in the book. …”

“…These include human immunodeficiency virus (HIV), Rous sarcoma virus (RSV), equine infectious anemia virus (EIAV), Mason-Pfizer monkey virus (M-PMV), murine leukemia virus (MLV), and human T-lymphotropic virus type (HTLV-1). …”

“…Con 150 menús y explicaciones sencillas resolverás no pocos problemas, y aprenderás a prevenir las anemias, el cáncer digestivo y el de mama, a no engordar, a bajar el colesterol y la hipertensión, a combatir el estreñimiento, a darle alivio a las enfermedades reumáticas, a cuidar la piel, el cerebro, los huesos y el corazón. …”

“…El argumento de este libro es que ni la ue ni los países árabes han sabido sacar a la región de su estancamiento económico y su anemia política…”

“…EI 19 % de ellos presentaba anemia leve o moderada y, por tanto, requerían del suministro de alimentos ricos en hierro, y del suplemento medicamentoso. …”
Enlace del recurso

“…Las enfermedades marcadoras de SIDA más frecuentemente diagnosticadas fueron el Síndrome de consunción o desgaste (26,6 por ciento) y la tuberculosis (20,98 por ciento); otros procesos asociados fueron anemia (39,59 por ciento), lesiones mucocutáneas (candidiosis oral y vaginal, lesiones por virus del herpes zoster), sepsis urinaria, malaria, neumonías bacterianas y parasitismo intestinal. …”

“…It is possible, but has not been shown conclusively, that the reduced heart and lung capacity of older persons lead to a lower tolerance for acute anemia than in younger persons. It seems reasonable, therefore, to maintain a higher transfusion trigger level for the elderly and ill patients than the younger and healthier ones. …”